Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars

Samsung Bioepis Surpasses ₩1T Revenue in 2023

Jan 25, 2024

Samsung Biologics revealed in its Q4 2024 Earnings that its subsidiary Samsung Bioepis surpassed ₩1T (1 trillion Korean won) annual revenue in 2023 for the first time in the company’s history.  This was due to the 8% growth in revenue from new product launches and sales expansion.

Parent company Samsung Biologics’ operating profit of over ₩1T was also a record high.  On 25 October 2023, Samsung Biologics reported its highest ever quarterly consolidated revenue of over ₩1T.